Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2025-12-24 @ 5:06 PM
Study NCT ID:
NCT00793650
Status:
TERMINATED
Last Update Posted:
2012-08-30
First Post:
2008-11-17
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-17
First Submit QC Date:
None
Study First Post Date:
2008-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-14
Results First Submit QC Date:
None
Results First Post Date:
2012-06-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-17
Last Update Post Date:
2012-08-30
Last Update Post Date Type:
ESTIMATED